View in EDS

Dose escalation study of a personalized peptide-based neoantigen vaccine (EVX-01) in patients with metastatic melanoma.

Saved in:
Bibliographic Details
Title: Dose escalation study of a personalized peptide-based neoantigen vaccine (EVX-01) in patients with metastatic melanoma.
Authors: Mørk SK; Department of Oncology, Copenhagen University Hospital, National Center for Cancer Immune Therapy (CCIT-DK), Herlev, Denmark sofie.kirial.moerk@regionh.dk., Skadborg SK; Department of Health Technology, Technical University of Denmark, Kgs. Lyngby, Denmark., Albieri B; Department of Oncology, Copenhagen University Hospital, National Center for Cancer Immune Therapy (CCIT-DK), Herlev, Denmark., Draghi A; Department of Oncology, Copenhagen University Hospital, National Center for Cancer Immune Therapy (CCIT-DK), Herlev, Denmark., Bol K; Medical Oncology, Radboudumc, Nijmegen, The Netherlands., Kadivar M; Department of Health Technology, Technical University of Denmark, Kgs. Lyngby, Denmark., Westergaard MCW; Department of Oncology, Copenhagen University Hospital, National Center for Cancer Immune Therapy (CCIT-DK), Herlev, Denmark., Stoltenborg Granhøj J; Department of Oncology, Copenhagen University Hospital, National Center for Cancer Immune Therapy (CCIT-DK), Herlev, Denmark., Borch A; Department of Health Technology, Technical University of Denmark, Kgs. Lyngby, Denmark., Petersen NV; Evaxion Biotech, Copenhagen, Denmark., Thuesen N; Evaxion Biotech, Copenhagen, Denmark., Rasmussen IS; Center for Vaccine Research, Statens Serum Institut, Copenhagen, Denmark., Andreasen LV; Center for Vaccine Research, Statens Serum Institut, Copenhagen, Denmark., Dohn RB; Center for Vaccine Research, Statens Serum Institut, Copenhagen, Denmark., Yde CW; Genomic Medicine, Rigshospitalet, Copenhagen, Denmark., Noergaard N; Department of Urology, Copenhagen University Hospital, Herlev, Denmark., Lorentzen T; Department of Gastroenterology, Copenhagen University Hospital, Herlev, Denmark., Soerensen AB; Evaxion Biotech, Copenhagen, Denmark., Kleine-Kohlbrecher D; Evaxion Biotech, Copenhagen, Denmark., Jespersen A; Evaxion Biotech, Copenhagen, Denmark., Christensen D; Center for Vaccine Research, Statens Serum Institut, Copenhagen, Denmark., Kringelum J; Evaxion Biotech, Copenhagen, Denmark., Donia M; Department of Oncology, Copenhagen University Hospital, National Center for Cancer Immune Therapy (CCIT-DK), Herlev, Denmark., Hadrup SR; Department of Health Technology, Technical University of Denmark, Kgs. Lyngby, Denmark., Marie Svane I; Department of Oncology, Copenhagen University Hospital, National Center for Cancer Immune Therapy (CCIT-DK), Herlev, Denmark.
Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2024 May 23; Vol. 12 (5). Date of Electronic Publication: 2024 May 23.
Publication Type: Clinical Study; Journal Article
Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38782542
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Dose escalation study of a personalized peptide-based neoantigen vaccine (EVX-01) in patients with metastatic melanoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Mørk+SK%22">Mørk SK</searchLink>; Department of Oncology, Copenhagen University Hospital, National Center for Cancer Immune Therapy (CCIT-DK), Herlev, Denmark sofie.kirial.moerk@regionh.dk.<br /><searchLink fieldCode="AU" term="%22Skadborg+SK%22">Skadborg SK</searchLink>; Department of Health Technology, Technical University of Denmark, Kgs. Lyngby, Denmark.<br /><searchLink fieldCode="AU" term="%22Albieri+B%22">Albieri B</searchLink>; Department of Oncology, Copenhagen University Hospital, National Center for Cancer Immune Therapy (CCIT-DK), Herlev, Denmark.<br /><searchLink fieldCode="AU" term="%22Draghi+A%22">Draghi A</searchLink>; Department of Oncology, Copenhagen University Hospital, National Center for Cancer Immune Therapy (CCIT-DK), Herlev, Denmark.<br /><searchLink fieldCode="AU" term="%22Bol+K%22">Bol K</searchLink>; Medical Oncology, Radboudumc, Nijmegen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Kadivar+M%22">Kadivar M</searchLink>; Department of Health Technology, Technical University of Denmark, Kgs. Lyngby, Denmark.<br /><searchLink fieldCode="AU" term="%22Westergaard+MCW%22">Westergaard MCW</searchLink>; Department of Oncology, Copenhagen University Hospital, National Center for Cancer Immune Therapy (CCIT-DK), Herlev, Denmark.<br /><searchLink fieldCode="AU" term="%22Stoltenborg+Granhøj+J%22">Stoltenborg Granhøj J</searchLink>; Department of Oncology, Copenhagen University Hospital, National Center for Cancer Immune Therapy (CCIT-DK), Herlev, Denmark.<br /><searchLink fieldCode="AU" term="%22Borch+A%22">Borch A</searchLink>; Department of Health Technology, Technical University of Denmark, Kgs. Lyngby, Denmark.<br /><searchLink fieldCode="AU" term="%22Petersen+NV%22">Petersen NV</searchLink>; Evaxion Biotech, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Thuesen+N%22">Thuesen N</searchLink>; Evaxion Biotech, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Rasmussen+IS%22">Rasmussen IS</searchLink>; Center for Vaccine Research, Statens Serum Institut, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Andreasen+LV%22">Andreasen LV</searchLink>; Center for Vaccine Research, Statens Serum Institut, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Dohn+RB%22">Dohn RB</searchLink>; Center for Vaccine Research, Statens Serum Institut, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Yde+CW%22">Yde CW</searchLink>; Genomic Medicine, Rigshospitalet, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Noergaard+N%22">Noergaard N</searchLink>; Department of Urology, Copenhagen University Hospital, Herlev, Denmark.<br /><searchLink fieldCode="AU" term="%22Lorentzen+T%22">Lorentzen T</searchLink>; Department of Gastroenterology, Copenhagen University Hospital, Herlev, Denmark.<br /><searchLink fieldCode="AU" term="%22Soerensen+AB%22">Soerensen AB</searchLink>; Evaxion Biotech, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Kleine-Kohlbrecher+D%22">Kleine-Kohlbrecher D</searchLink>; Evaxion Biotech, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Jespersen+A%22">Jespersen A</searchLink>; Evaxion Biotech, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Christensen+D%22">Christensen D</searchLink>; Center for Vaccine Research, Statens Serum Institut, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Kringelum+J%22">Kringelum J</searchLink>; Evaxion Biotech, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Donia+M%22">Donia M</searchLink>; Department of Oncology, Copenhagen University Hospital, National Center for Cancer Immune Therapy (CCIT-DK), Herlev, Denmark.<br /><searchLink fieldCode="AU" term="%22Hadrup+SR%22">Hadrup SR</searchLink>; Department of Health Technology, Technical University of Denmark, Kgs. Lyngby, Denmark.<br /><searchLink fieldCode="AU" term="%22Marie+Svane+I%22">Marie Svane I</searchLink>; Department of Oncology, Copenhagen University Hospital, National Center for Cancer Immune Therapy (CCIT-DK), Herlev, Denmark.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101620585%22">Journal for immunotherapy of cancer</searchLink> [J Immunother Cancer] 2024 May 23; Vol. 12 (5). <i>Date of Electronic Publication: </i>2024 May 23.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Study; Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BMJ+Publishing+Group+Ltd%22">BMJ Publishing Group Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101620585 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2051-1426 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220511426%22">20511426 </searchLink><i>NLM ISO Abbreviation: </i>J Immunother Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38782542
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1136/jitc-2024-008817
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Dose escalation study of a personalized peptide-based neoantigen vaccine (EVX-01) in patients with metastatic melanoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Mørk SK
      – PersonEntity:
          Name:
            NameFull: Skadborg SK
      – PersonEntity:
          Name:
            NameFull: Albieri B
      – PersonEntity:
          Name:
            NameFull: Draghi A
      – PersonEntity:
          Name:
            NameFull: Bol K
      – PersonEntity:
          Name:
            NameFull: Kadivar M
      – PersonEntity:
          Name:
            NameFull: Westergaard MCW
      – PersonEntity:
          Name:
            NameFull: Stoltenborg Granhøj J
      – PersonEntity:
          Name:
            NameFull: Borch A
      – PersonEntity:
          Name:
            NameFull: Petersen NV
      – PersonEntity:
          Name:
            NameFull: Thuesen N
      – PersonEntity:
          Name:
            NameFull: Rasmussen IS
      – PersonEntity:
          Name:
            NameFull: Andreasen LV
      – PersonEntity:
          Name:
            NameFull: Dohn RB
      – PersonEntity:
          Name:
            NameFull: Yde CW
      – PersonEntity:
          Name:
            NameFull: Noergaard N
      – PersonEntity:
          Name:
            NameFull: Lorentzen T
      – PersonEntity:
          Name:
            NameFull: Soerensen AB
      – PersonEntity:
          Name:
            NameFull: Kleine-Kohlbrecher D
      – PersonEntity:
          Name:
            NameFull: Jespersen A
      – PersonEntity:
          Name:
            NameFull: Christensen D
      – PersonEntity:
          Name:
            NameFull: Kringelum J
      – PersonEntity:
          Name:
            NameFull: Donia M
      – PersonEntity:
          Name:
            NameFull: Hadrup SR
      – PersonEntity:
          Name:
            NameFull: Marie Svane I
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 23
              M: 05
              Text: 2024 May 23
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 2051-1426
          Numbering:
            – Type: volume
              Value: 12
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: Journal for immunotherapy of cancer
              Type: main
ResultId 1